Your browser doesn't support javascript.
loading
Efficiency and Tolerability of Induction and Consolidation Therapy with Arsenic Trioxide/Bortezomib/Ascorbic Acid/Dexamethasone (ABCD) Regimen Compared to Bortezomib/Dexamethasone (BD) Regimen in Newly Diagnosed Myeloma Patients.
Qian, Wensi; Wang, Li; Li, Pei; Hu, Yingwei; Wang, Qian; Yi, Ke; Wu, Min; Xu, Yu; Song, Jin; Chen, Pingping; Zhang, Hongdi; Ma, Jiexian; Xie, Yanhui.
Afiliación
  • Qian W; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Wang L; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Qingdao, People's Republic of China.
  • Li P; Department of Hematology, Huashan Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Hu Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Wang Q; Department of Hematology, Huashan Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Yi K; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Wu M; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Xu Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Song J; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Chen P; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Zhang H; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Ma J; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
  • Xie Y; Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital Affiliated with Fudan University, Shanghai, People's Republic of China.
Cancer Manag Res ; 12: 431-441, 2020.
Article en En | MEDLINE | ID: mdl-32021455

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article Pais de publicación: Nueva Zelanda